Bioactivities from Marine Algae of the Genus Gracilaria

Seaweeds are an important source of bioactive metabolites for the pharmaceutical industry in drug development. Many of these compounds are used to treat diseases like cancer, acquired immune-deficiency syndrome (AIDS), inflammation, pain, arthritis, as well as viral, bacterial, and fungal infections...

Descripción completa

Detalles Bibliográficos
Autores principales: de Almeida, Cynthia Layse F., Falcão, Heloina de S., Lima, Gedson R. de M., Montenegro, Camila de A., Lira, Narlize S., de Athayde-Filho, Petrônio F., Rodrigues, Luis C., de Souza, Maria de Fátima V., Barbosa-Filho, José M., Batista, Leônia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155369/
https://www.ncbi.nlm.nih.gov/pubmed/21845096
http://dx.doi.org/10.3390/ijms12074550
Descripción
Sumario:Seaweeds are an important source of bioactive metabolites for the pharmaceutical industry in drug development. Many of these compounds are used to treat diseases like cancer, acquired immune-deficiency syndrome (AIDS), inflammation, pain, arthritis, as well as viral, bacterial, and fungal infections. This paper offers a survey of the literature for Gracilaria algae extracts with biological activity, and identifies avenues for future research. Nineteen species of this genus that were tested for antibacterial, antiviral, antifungal, antihypertensive, cytotoxic, spermicidal, embriotoxic, and anti-inflammatory activities are cited from the 121 references consulted.

Ejemplares similares